共 38 条
- [1] Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy A Propensity Score Analysis [J]. OPHTHALMOLOGY SCIENCE, 2022, 2 (02):
- [4] Barde Mohini P, 2012, Perspect Clin Res, V3, P113, DOI 10.4103/2229-3485.100662
- [6] Breukink MB, 2017, CLIN OPHTHALMOL, V11, P39, DOI 10.2147/OPTH.S115685
- [8] ACUTE CENTRAL SEROUS CHORIORETINOPATHY Factors Influencing Episode Duration [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (10): : 1905 - 1915
- [9] INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2023, 43 (03): : 379 - 388
- [10] TYPE 1 (SUB-RETINAL PIGMENT EPITHELIAL) NEOVASCULARIZATION IN CENTRAL SEROUS CHORIORETINOPATHY MASQUERADING AS NEOVASCULAR AGE-RELATED MACULAR DEGENERATION [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (09): : 1829 - 1837